GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Capex-to-Revenue

Biogena Group Invest AG (WBO:BIO) Capex-to-Revenue : 0.00 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Biogena Group Invest AG's Capital Expenditure for the six months ended in Jan. 2024 was €0.00 Mil. Its Revenue for the six months ended in Jan. 2024 was €0.17 Mil.

Hence, Biogena Group Invest AG's Capex-to-Revenue for the six months ended in Jan. 2024 was 0.00.


Biogena Group Invest AG Capex-to-Revenue Historical Data

The historical data trend for Biogena Group Invest AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Capex-to-Revenue Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Capex-to-Revenue
- - - -

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Capex-to-Revenue - - - -

Competitive Comparison of Biogena Group Invest AG's Capex-to-Revenue

For the Packaged Foods subindustry, Biogena Group Invest AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Capex-to-Revenue falls into.



Biogena Group Invest AG Capex-to-Revenue Calculation

Biogena Group Invest AG's Capex-to-Revenue for the fiscal year that ended in Jan. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.166
=0.00

Biogena Group Invest AG's Capex-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.166
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Biogena Group Invest AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.